Want Us To Contact You?
JUVÉDERM VOLBELLA® XC
We are pleased to introduce the newest addition to our collection of injectable fillers – JUVÉDERM VOLBELLA® XC. This remarkable product has been granted FDA approval for lip augmentation and correction of perioral rhytids, commonly known as perioral lines, for adults over the age of 21.
What should you know about JUVEDERM VOLBELLA® XC?
- Clinical trials have demonstrated the efficacy of JUVÉDERM VOLBELLA® XC in increasing lip fullness and softening the appearance of perioral lines in a majority of subjects over the course of one year. Moreover, patients may opt to receive a touch-up treatment one month after the initial treatment for optimal correction.
- To formulate JUVÉDERM VOLBELLA® XC, we have utilized our proprietary VYCROSS® filler technology, which guarantees a smooth and precise product to address specific patient concerns. Our commitment to innovation and patient satisfaction is reflected in every JUVÉDERM VOLBELLA® XC treatment.
- JUVÉDERM VOLBELLA® XC distinguishes itself from other injectable fillers through its unique VYCROSS® technology, which expertly blends different molecular weights of hyaluronic acid to lengthen the gel’s duration. Notably, this solution has been customized with a lower HA concentration (15 mg/mL) to deliver the long-lasting results that healthcare providers expect from the esteemed JUVÉDERM® collection of fillers.
- JUVÉDERM VOLBELLA® XC achieves a soft, smooth gel consistency ideal for adding subtle volume to lips and targeting perioral lines. This latest advancement follows the introduction of VYCROSS® technology by Allergan in 2013 with the FDA-approved JUVÉDERM VOLUMA® XC solution to address age-related mid-face volume loss. Now, JUVÉDERM VOLBELLA® XC has garnered FDA approval as the latest addition to the number one selling collection of dermal filler products in the world – the JUVÉDERM® collection.
- Dr. Fraker is excited to offer our patients the latest innovation in injectable fillers – JUVÉDERM VOLBELLA® XC – for the correction of perioral rhytids, more commonly known as perioral lines. Historically, this delicate area has posed a challenge for healthcare providers seeking to deliver optimal aesthetic results. Fortunately, JUVEDERM® Collection of Fillers now offers a solution that has earned FDA approval to address this very concern.
- Patients seeking cosmetic treatments for their lips commonly desire a smooth, natural-looking outcome. JUVÉDERM VOLBELLA® XC has been specially formulated to address the specific issues surrounding the lips and perioral lines. This unique product adds fullness to the lips while simulta
- JUVÉDERM VOLBELLA® XC has been meticulously tested and studied to establish its safety and effectiveness. Clinical trials, including a U.S. pivotal study that involved 168 subjects, have employed a 5-point scale to evaluate the product’s efficacy in promoting lip fullness, and a 4-point scale to assess the product’s effectiveness in smoothing lines around the mouth.
- Impressively, approximately two-thirds of the subjects treated with this solution reported an improvement in lip fullness and perioral lines over one year. The safety of JUVÉDERM VOLBELLA® XC was observed to be on par with that of the control group in these studies.
Like any medical treatment, there may be side effects associated with the use of JUVÉDERM VOLBELLA® XC. Common temporary responses at the treatment site include swelling, tenderness, bruising, firmness lumps/bumps, redness, pain, discoloration, and itching. However, it’s important to note that most of these side effects resolve within 30 days, and our healthcare providers will take every precaution necessary to ensure your comfort.
Indulge in the Ultimate Pampering at the Most Popular Aesthetic Treatment Clinic
Reveal your radiance and redefine your beauty with our transformative medi spa treatments.